Stock Price Targets and Analyst Ratings All RatingsU.S.U.K.CanadianUpgradesDowngradesInitiationsPrice Target ChangesMore Reporting Date Country USA (NYSE & NASDAQ) United States(NYSE & NASDAQ) United States(All Exchanges) Canada United Kingdom Sector All Sectors Aerospace Auto/Tires/Trucks Basic Materials Business Services Computer and Technology Construction Consumer Discretionary Consumer Goods Consumer Staples Finance Industrial Products Medical Miscellaneous Multi-Sector Conglomerates Oils/Energy Retail/Wholesale Services Transportation Utilities All Market Caps Large Cap ($10B+) Medium Cap ($2B-$10B) Small Cap (<$2B) Market Cap All Ratings Strong Buy Buy Hold Sell Rating Export to Excel CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetailsAIRJMontana Technologies Initiated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingA. DayalSubscribe to MarketBeat All Access for the recommendation accuracy rating$9.50+0.7% $12.00BuyAPLDApplied Digital Initiated byCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingB. KnoblauchSubscribe to MarketBeat All Access for the recommendation accuracy rating$8.01-0.5% $15.00OverweightAROWArrow Financial Initiated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingF. SchiraldiSubscribe to MarketBeat All Access for the recommendation accuracy rating$29.00+1.2% $32.00NeutralATRAAtara Biotherapeutics Initiated byRodman & RenshawSubscribe to MarketBeat All Access for the recommendation accuracy rating$11.40+14.8% $25.00BuyCHMGChemung Financial Initiated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingF. SchiraldiSubscribe to MarketBeat All Access for the recommendation accuracy rating$50.05+0.7% $57.00NeutralCRCCalifornia Resources Initiated byJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy rating$50.56-0.8% $63.00NeutralURGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop NowDHDefinitive Healthcare Initiated byStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingJ. GarroSubscribe to MarketBeat All Access for the recommendation accuracy rating$4.18+1.0% $5.00Equal WeightDNTHDianthus Therapeutics Initiated byTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingY. WerberSubscribe to MarketBeat All Access for the recommendation accuracy rating$23.80+3.3%BuyDOCSDoximity Initiated byStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingJ. GarroSubscribe to MarketBeat All Access for the recommendation accuracy rating$57.83+4.8% $55.00Equal WeightFICOFair Isaac Initiated byJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy rating$2,090.98+2.3% $2,150.00NeutralFISIFinancial Institutions Initiated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingF. SchiraldiSubscribe to MarketBeat All Access for the recommendation accuracy rating$27.12+1.8% $33.00OverweightIQVIQVIA Initiated byStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingJ. GarroSubscribe to MarketBeat All Access for the recommendation accuracy rating$197.27+3.0% $250.00OverweightIRENIris Energy Initiated byBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingG. LewisSubscribe to MarketBeat All Access for the recommendation accuracy rating$11.81+3.5% $33.00BuyLCNBLCNB Initiated byHovde GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingB. NosalSubscribe to MarketBeat All Access for the recommendation accuracy rating$15.24-3.0% $16.25Market PerformLQDALiquidia Initiated byWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingT. FauthSubscribe to MarketBeat All Access for the recommendation accuracy rating$11.10+4.8% $20.00OverweightMCOMoody's Initiated byCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingP. ChristiansenSubscribe to MarketBeat All Access for the recommendation accuracy rating$466.35+0.9% $565.00BuyMNKDMannKind Initiated byWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingT. FauthSubscribe to MarketBeat All Access for the recommendation accuracy rating$6.85+8.7% $9.00OverweightMNMDMind Medicine (MindMed) Initiated byChardan CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingR. LiSubscribe to MarketBeat All Access for the recommendation accuracy rating$7.16+2.1% $20.00BuyMPAAMotorcar Parts of America Initiated byCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingD. SoderbergSubscribe to MarketBeat All Access for the recommendation accuracy rating$7.91+1.3% $14.00OverweightNRIMNorthrim BanCorp Initiated byHovde GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingB. RabatinSubscribe to MarketBeat All Access for the recommendation accuracy rating$76.48-0.8% $96.50OutperformOPRXOptimizeRx Initiated byStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingJ. GarroSubscribe to MarketBeat All Access for the recommendation accuracy rating$4.91+3.4% $5.50Equal WeightPAYSPaysign Initiated byLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy rating$2.99+2.0% $6.00BuyPCVXVaxcyte Initiated byThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingC. ShibutaniSubscribe to MarketBeat All Access for the recommendation accuracy rating$86.53+0.4% $135.00BuyPFLTPennantPark Floating Rate Capital Initiated byRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingR. DoddSubscribe to MarketBeat All Access for the recommendation accuracy rating$10.68-0.3%Market PerformPGYPagaya Technologies Initiated byUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$8.95+2.8%$33.00 ➝ $11.00Neutral ➝ NeutralPRTAProthena Initiated byChardan CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingR. LiSubscribe to MarketBeat All Access for the recommendation accuracy rating$15.22-4.9% $40.00BuyRDDTReddit Initiated byGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingM. MorrisSubscribe to MarketBeat All Access for the recommendation accuracy rating$170.71+4.3% $210.00BuyRGTIRigetti Computing Initiated byCraig HallumSubscribe to MarketBeat All Access for the recommendation accuracy ratingR. ShannonSubscribe to MarketBeat All Access for the recommendation accuracy rating$9.37+25.4% $12.00BuyRNAAvidity Biosciences Initiated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingA. GhoshSubscribe to MarketBeat All Access for the recommendation accuracy rating$31.82+2.5% $72.00BuyRYTMRhythm Pharmaceuticals Initiated byOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy rating$56.12+1.2% $76.00OutperformSPGIS&P Global Initiated byCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingP. ChristiansenSubscribe to MarketBeat All Access for the recommendation accuracy rating$491.81+1.1% $600.00BuySTOKStoke Therapeutics Initiated byChardan CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingR. LiSubscribe to MarketBeat All Access for the recommendation accuracy rating$11.68+3.4% $24.00BuySVRASavara Initiated byWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingT. FauthSubscribe to MarketBeat All Access for the recommendation accuracy rating$3.23 $8.00OverweightVEEVVeeva Systems Initiated byStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingJ. GarroSubscribe to MarketBeat All Access for the recommendation accuracy rating$224.15+2.0% $280.00OverweightVITLVital Farms Initiated byCraig HallumSubscribe to MarketBeat All Access for the recommendation accuracy ratingE. LauriersSubscribe to MarketBeat All Access for the recommendation accuracy rating$39.69+2.5% $50.00BuyVVVValvoline Initiated byStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy rating$36.55+0.8% $42.00HoldAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 12:03 PM ET. Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.